PATENT CLAIM ANALYSIS

Application Number: 16148601
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "017800"]

Abstract:
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.

Claim (Index 10):
The method of  claim 1  wherein the cell expressing the antibody or binding fragment thereof or the nucleic acid molecule encoding the antibody of or binding fragment thereof is administered, optionally wherein the nucleic acid molecule is comprised in a vector.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 97.0
- Lexical Diversity: 1.20513
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11304986', '14967260', '13701151', '10642099', '14383602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.790983366759214
- 35 USC 102 Novelty (BERT): 0.531099219935525
- Combined Prediction Score: 0.7649949520768451
- Mean Citation Score: 329.930246
- Max Citation Score: 341.01526
- Similarity Product: 271.97390299366714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test